Management of Severe Hypercholesterolemia in Patients Receiving Atypical AntipsychoticsInitial High‑Intensity Statin TherapyEscalation with EzetimibeFurther Escalation with PCSK9 InhibitorsRisk‑Based LDL‑C TargetsSpecial Considerations for Metabolic RiskMonitoring and Safety